Senate
Study
Bill
3012
-
Introduced
SENATE/HOUSE
FILE
_____
BY
(PROPOSED
BOARD
OF
PHARMACY
BILL)
A
BILL
FOR
An
Act
relating
to
in-state
special
or
limited-use
pharmacy
1
licensure
and
nonresident
pharmacy
practices,
licensure,
and
2
discipline.
3
BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
4
TLSB
5260DP
(3)
85
ad/nh
S.F.
_____
H.F.
_____
Section
1.
Section
155A.13,
subsections
3
and
5,
Code
2014,
1
are
amended
to
read
as
follows:
2
3.
The
board
may
issue
a
special
or
limited-use
pharmacy
3
license
or
a
telepharmacy
license
based
upon
special
conditions
4
of
use
imposed
pursuant
to
rules
adopted
by
the
board
for
cases
5
in
which
the
board
determines
that
certain
requirements
may
be
6
waived.
7
5.
A
hospital
which
elects
to
operate
a
pharmacy
for
other
8
than
its
own
use
is
subject
to
the
requirements
for
a
general
9
pharmacy
license.
If
the
hospital’s
pharmacy
services
for
10
other
than
its
own
use
are
special
or
limited,
the
board
11
may
issue
a
special
or
limited-use
pharmacy
license
or
a
12
telepharmacy
license
pursuant
to
subsection
3
.
13
Sec.
2.
Section
155A.13A,
subsection
2,
Code
2014,
is
14
amended
to
read
as
follows:
15
2.
License
renewal.
A
nonresident
pharmacy
shall
renew
its
16
license
on
or
before
January
1
annually.
In
order
to
renew
17
a
nonresident
pharmacy
license,
a
nonresident
pharmacy
shall
18
submit
a
renewal
application
and
fee
as
determined
by
the
19
board,
and
shall
fulfill
all
of
the
requirements
of
subsection
20
1
,
paragraphs
“b”
through
“e”
.
A
nonresident
pharmacy
shall
pay
21
an
additional
fee
for
late
renewal
as
determined
by
the
board.
22
Sec.
3.
Section
155A.13A,
Code
2014,
is
amended
by
adding
23
the
following
new
subsections:
24
NEW
SUBSECTION
.
2A.
Pharmacist
licensure
requirement.
At
25
least
one
pharmacist
employed
by
the
nonresident
pharmacy,
who
26
shall
be
designated
the
pharmacist
in
charge
of
the
nonresident
27
pharmacy,
shall
maintain
a
current
license
to
practice
pharmacy
28
in
Iowa
during
any
period
that
the
nonresident
pharmacy
is
29
licensed
by
the
board.
30
NEW
SUBSECTION
.
2B.
Sterile
compounding
practice.
A
31
nonresident
pharmacy
that
engages
in
the
preparation
of
any
32
sterile
compounded
product
for
dispensing
to
or
for
a
patient
33
located
in
Iowa
shall
comply
with
rules
relating
to
sterile
34
compounding
practices
adopted
by
the
board.
A
nonresident
35
-1-
LSB
5260DP
(3)
85
ad/nh
1/
3
S.F.
_____
H.F.
_____
pharmacy
engaging
in
sterile
compounding
shall
pay
an
amount
1
necessary
to
cover
the
board’s
costs
of
conducting
periodic
2
inspections
of
the
pharmacy’s
operations.
Costs
recovered
3
pursuant
to
this
subsection
shall
be
considered
repayment
4
receipts
as
defined
in
section
8.2.
5
NEW
SUBSECTION
.
2C.
Inspections.
The
board
may
inspect
the
6
premises
and
practices
of
any
applicant
for
a
new
nonresident
7
pharmacy
license
or
for
renewal
of
a
nonresident
pharmacy
8
license.
9
Sec.
4.
Section
155A.13A,
subsection
3,
Code
2014,
is
10
amended
to
read
as
follows:
11
3.
Discipline.
The
board
may
deny
an
application
for
a
12
new
or
renewal
of
a
nonresident
pharmacy
license
if
an
agent
13
of
the
board
is
refused
access
to
the
pharmacy
or
pharmacy
14
records
for
the
purpose
of
conducting
a
periodic
inspection
15
or
investigation.
The
board
may
deny,
suspend,
or
revoke
a
16
nonresident
pharmacy
license
for
any
violation
of
this
section
,
17
section
155A.15,
subsection
2
,
paragraph
“a”
,
“b”
,
“d”
,
“e”
,
18
“f”
,
“g”
,
“h”
,
or
“i”
,
chapter
124
,
124A
,
124B
,
126
,
or
205
,
or
19
a
rule
of
the
board.
20
Sec.
5.
Section
155A.15,
subsection
1,
Code
2014,
is
amended
21
to
read
as
follows:
22
1.
a.
A
pharmacy
subject
to
section
155A.13
shall
not
be
23
operated
until
a
license
or
renewal
certificate
has
been
issued
24
to
the
pharmacy
by
the
board.
25
b.
A
pharmacy
subject
to
section
155A.13A
shall
not
offer
26
or
provide
pharmaceutical
services
to
patients
located
in
Iowa
27
until
a
license
or
renewal
certificate
has
been
issued
to
the
28
pharmacy
by
the
board.
29
EXPLANATION
30
The
inclusion
of
this
explanation
does
not
constitute
agreement
with
31
the
explanation’s
substance
by
the
members
of
the
general
assembly.
32
This
bill
relates
to
in-state
special
or
limited-use
33
pharmacy
licensure
and
nonresident
pharmacy
practices,
34
licensure,
and
discipline.
The
bill
eliminates
references
35
-2-
LSB
5260DP
(3)
85
ad/nh
2/
3
S.F.
_____
H.F.
_____
to
special
pharmacy
licenses.
The
bill
allows
the
board
of
1
pharmacy
to
issue
telepharmacy
licenses
pursuant
to
the
rules
2
of
the
board.
3
The
bill
amends
the
requirements
and
practices
for
licensure
4
of
a
nonresident
pharmacy.
A
licensed
nonresident
pharmacy
5
must
submit
an
application
for
renewal
of
its
license.
The
6
bill
also
requires
the
pharmacist
in
charge
of
a
nonresident
7
pharmacy
to
have
a
license
to
practice
pharmacy
in
Iowa.
8
The
bill
prohibits
a
nonresident
pharmacy
from
providing
9
pharmaceutical
services
to
a
patient
in
Iowa
until
the
pharmacy
10
is
licensed
by
the
board.
11
The
bill
requires
pharmacies
to
comply
with
the
rules
12
of
the
board
for
the
preparation
of
sterile
compounding
13
products
when
engaging
in
the
sterile
compounding
of
any
14
product
for
dispensing
to
or
for
a
patient
located
in
Iowa
and
15
also
requires
these
pharmacies
to
pay
the
board’s
costs
in
16
conducting
inspections
of
the
nonresident
pharmacy’s
sterile
17
compounding
operations.
The
bill
authorizes
the
board
to
18
inspect
the
premises
and
practices
of
applicants
for
a
new
19
nonresident
pharmacy
license
or
for
renewal
of
a
nonresident
20
pharmacy
license.
21
The
bill
states
that
the
board
may
deny
an
application
for
22
a
new
or
renewal
of
a
nonresident
pharmacy
license
if
the
23
pharmacy
refuses
the
board
access
to
the
pharmacy
or
pharmacy
24
records.
25
The
bill
adds
to
the
list
of
violations
that
could
lead
to
a
26
denial,
suspension,
or
revocation
of
a
nonresident
pharmacy’s
27
license.
These
additional
violations
include
operating
a
28
nonresident
pharmacy
without
a
license
and
a
violation
by
the
29
pharmacy
or
a
pharmacist
of
any
provision
in
the
pharmacy
30
chapter
or
rule
adopted
pursuant
to
the
chapter.
31
-3-
LSB
5260DP
(3)
85
ad/nh
3/
3